A Biomimetic Nanomedicine Targets Orthotopic Glioblastoma by Combinatorial Co‐Delivery of Temozolomide and a Methylguanine‐DNA Methyltransferase Inhibitor-Reference-Cited by-同舟云学术

A Biomimetic Nanomedicine Targets Orthotopic Glioblastoma by Combinatorial Co‐Delivery of Temozolomide and a Methylguanine‐DNA Methyltransferase Inhibitor

Published:2022-09-20 Issue:12 Volume:5 Page:2200095
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Advanced Therapeutics

Author:

Wang Yibin¹²,Sun Yajing¹²,Geng Nan¹²,Zheng Meng¹²,Zou Yan¹²³,Shi Bingyang¹²³^ORCID

Affiliation:

1. Henan‐Macquarie Uni Joint Centre for Biomedical Innovation School of Life Sciences Henan University Kaifeng Henan 475004 China

2. Henan Key Laboratory of Brain Targeted Bio‐nanomedicine School of Life Sciences Henan University Kaifeng Henan 475004 China

3. Macquarie Medical School Faculty of Medicine Health and Human Sciences Macquarie University Sydney NSW 2109 Australia

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry (medical),Genetics (clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.202200095

Reference48 articles.

1. Management of glioblastoma: State of the art and future directions

2. Current state of immunotherapy for glioblastoma

3. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

4. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

5. Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stimuli-Responsive Polymeric Nanocarriers Accelerate On-Demand Drug Release to Combat Glioblastoma;Biomacromolecules;2024-09-11

2. Brain‐Targeted Cas12a Ribonucleoprotein Nanocapsules Enable Synergetic Gene Co‐Editing Leading to Potent Inhibition of Orthotopic Glioblastoma;Advanced Science;2024-06-28

3. Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma;ACS Nano;2024-06-11

4. Blood-brain barrier penetrating nanosystems enable synergistic therapy of glioblastoma;Nano Today;2024-06

5. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma;Journal of Nanobiotechnology;2024-05-17